Search results
Showing 7816 to 7830 of 8314 results
Home What NICE does NICE International {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1
Find out more about the types of organisations that can register to be a stakeholder at NICE.
Our stakeholders are involved in the development of NICE guidance and quality standards to ensure that the recommendations are relevant, practical, and meet the needs of those affected by the health or social care issues addressed.
Early Cancer Diagnosis: 75% of cases diagnosed at stage 1 or 2 by 2028.
Smoking cessation positively impacts all 5 clinical areas identified by Core20PLUS5 adults.
Ensure annual physical health checks for people with severe mental illness to at least nationally set targets.
Hypertension case finding and optimal management and lipid optimal management
Home Implementing NICE guidance Cost saving, resource planning and audit NICE and health inequalities NICE and Core20PLUS5 - adults...
A clear focus on Chronic Obstructive Pulmonary Disease (COPD) driving up uptake of Covid, Flu and Pneumonia vaccines to reduce infective exacerbations and emergency hospital admissions due to those exacerbations.
The guidance development timeline
Information and benefits about shared decision making. Includes links to patient decision aids.
NICE works with partners including Public Health England, NHS England and NHS Improvement to assess services and support innovation and best practice.
Guide for lay members who we've invited to sit on one of NICE's committees, panels, or groups.
Home Get involved Our committees...
People coming off obesity medication or finishing a weight management programme should be offered support to help keep the weight off and stay healthy long-term, according to our updated quality standard.
Patients to receive medicines 3 to 6 months faster under 10-Year Health Plan
NICE and the Medicines and Healthcare products Regulatory Agency (MHRA) have described how the 10-Year Health Plan will lead to faster medicines access for patients in the NHS in England.